ScholarLens Back to search
2003•Unpublished venueRequires access

Local Immunotherapy in Allergy

David Lawson Morris, George F. Kroker, Vijay K. Sabnis, Mary S. Morris

Open publisher page 1 citations

Abstract

UNLABELLED: Specific immunotherapy is a very powerful tool which is currently underutilized in the treatment of allergies. Sublingual immunotherapy (SLIT) has many advantages over subcutaneous immunotherapy (SCIT), and has been well proven to work for many pollens and dust mites. Multiple studies have shown SLIT improves symptoms and reduces the reliance on medications. Sublingual treatment has been studied in Europe and is endorsed by the World Health Organization Committee on Immunotherapy as a viable alternative to SCIT. CONCLUSION: SLIT offers another option for patients who are not currently candidates for subcutaneous immunotherapy. Because of improved safety, convenience and compliance, sublingual immunotherapy should be used as a first-line treatment option.

About this research paper

What this paper is about

UNLABELLED: Specific immunotherapy is a very powerful tool which is currently underutilized in the treatment of allergies. Sublingual immunotherapy (SLIT) has many advantages over subcutaneous immunotherapy (SCIT), and has been well proven to work for many pollens and dust mites. Multiple studies have shown SLIT improves symptoms and reduces the reliance on medications. Sublingual treatment has been studied in Europe and is endorsed by the World Health Organization Committee on Immunotherapy as a viable alternative to SCIT. CONCLUSION: SLIT offers another option for patients who are not currently candidates for subcutaneous immunotherapy. Because of improved safety, convenience and compliance, sublingual immunotherapy should be used as a first-line treatment option.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

UNLABELLED: Specific immunotherapy is a very powerful tool which is currently underutilized in the treatment of allergies. Sublingual immunotherapy (SLIT) has many advantages over subcutaneous immunotherapy (SCIT), and has been well proven to work for many pollens and dust mites. Multiple studies have shown SLIT improves symptoms and reduces the reliance on medications. Sublingual treatment has been studied in Europe and is endorsed by the World Health Organization Committee on Immunotherapy as a viable alternative to SCIT. CONCLUSION: SLIT offers another option for patients who are not currently candidates for subcutaneous immunotherapy. Because of improved safety, convenience and compliance, sublingual immunotherapy should be used as a first-line treatment option.

Key concepts: Sublingual immunotherapy, Slit, Immunotherapy, Medicine, Allergy, First line, Dermatology, Intensive care medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Local Immunotherapy in Allergy — Research Paper | ScholarLens